Early and widespread cholinergic losses differentiate dementia with Lewy bodies from Alzheimer disease.
about
Excessive hippocampal acetylcholine levels in acetylcholinesterase-deficient mice are moderated by butyrylcholinesterase activityProton MRS in mild cognitive impairment.Magnetic resonance spectroscopy in Alzheimer's disease.Magnetic resonance spectroscopy in common dementiasStructural grey matter changes in the substantia innominata in Alzheimer's disease and dementia with Lewy bodies: a DARTEL-VBM studyModeling the association between 43 different clinical and pathological variables and the severity of cognitive impairment in a large autopsy cohort of elderly persons.Using mice to model Alzheimer's dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse modelsCapgras-like visual decomposition in Lewy body dementia with therapeutic response to donepezil.Association cortex hypoperfusion in mild dementia with Lewy bodies: a potential indicator of cholinergic dysfunction?Carriers of a common variant in the dopamine transporter gene have greater dementia risk, cognitive decline, and faster ventricular expansion.Role of cholinesterase inhibitors in Parkinson's disease and dementia with Lewy bodies.Thalamic Involvement in Fluctuating Cognition in Dementia with Lewy Bodies: Magnetic Resonance EvidencesImaging and acetylcholinesterase inhibitor response in dementia with Lewy bodies.The basal ganglia cholinergic neurochemistry of progressive supranuclear palsy and other neurodegenerative diseases.Dementia with Lewy bodies: current concepts.Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literatureDonepezil: an update.Cognitive Correlates of Basal Forebrain Atrophy and Associated Cortical Hypometabolism in Mild Cognitive ImpairmentDistinguishing Lewy body dementias from Alzheimer's disease.1H magnetic resonance spectroscopy in dementia.SPECT imaging in dementia.Neuropsychological assessment of dementia.Focal atrophy in dementia with Lewy bodies on MRI: a distinct pattern from Alzheimer's disease.Patterns of atrophy differ among specific subtypes of mild cognitive impairment.1H MR spectroscopy in common dementiasThe cholinergic system and Parkinson disease.Cholinergic dysfunction in Parkinson's disease.Visual spatial cognition in neurodegenerative diseaseBiomarkers in dementia with Lewy bodies: a review.Neuropsychiatric symptoms in patients with dementias associated with cortical Lewy bodies: pathophysiology, clinical features, and pharmacological management.Clinical trials: past, current, and future for atypical Parkinsonian syndromes.Prodromal dementia with Lewy bodies.Synaptic failure and α-synuclein.Cholinesterase inhibitory effects of Rhizophora lamarckii, Avicennia officinalis, Sesuvium portulacastrum and Suaeda monica: Mangroves inhabiting an Indian coastal area (Vellar Estuary).Improvement of Visuo-spatial Function Assessed by Raven's Colored Progressive Matrices in Dementia with Lewy Bodies by Donepezil Treatment.Loss of EEG Network Efficiency Is Related to Cognitive Impairment in Dementia With Lewy Bodies.Medial temporal lobe atrophy and APOE genotype do not predict cognitive improvement upon treatment with rivastigmine in Alzheimer's disease patients.The first genetic biomarker for dementia with Lewy bodies.Complex visual hallucinations as post-ictal cortical release phenomena.Long reaction times are associated with delayed brain activity in lewy body dementia.
P2860
Q28586552-B65CFBA1-4BC7-482E-A1C9-675890465F25Q30606675-25EDE3D1-049A-46B5-98F5-B2886A41548EQ30630699-8B09FB3D-A756-4A51-8423-22ACD75C8965Q30660402-B2F69D95-D110-4FC7-A4FF-FD4843BC4103Q33697892-4B821F24-CC9A-4E47-B891-CC73AD097670Q33828911-0FFE0776-0B02-47F1-AEF5-AEEC01773109Q34418781-45C714E4-5DBA-4687-9541-4730D3C7FA9EQ34777851-6EB84417-76A6-4493-A8B7-8346A7EAA312Q35064960-F278CF01-2DA0-4CB0-8BCB-91F29C9F31FCQ35733219-4A120C71-D537-4BDA-8779-A5237433DB50Q35863422-2F241DD8-92B3-4501-A372-4F8E02CDA794Q36098778-6E75D69D-FF3B-4A3B-A647-711719315F88Q36124416-EBE365B7-F4A6-463D-B878-FBFA622378B3Q36143785-763F3D04-EE21-4934-8875-3A5CCB1E4230Q36262742-40F139EB-3602-4FFD-A103-1D250E20559AQ36575903-0B484400-96B4-4CB9-A31C-9482E10D5882Q36808057-FBAF9655-800E-41B9-A59B-6B5403E98FA8Q36908486-79B7B7F6-57F3-42E9-8FAF-B16ADD7960B6Q36998833-96ECC47B-8947-4F08-95DE-317BBA0936F9Q37150637-55DF2458-11F9-4CA6-A3BA-E78DB116271FQ37150640-0E75A0E2-8DC6-4552-A504-532F54460F9DQ37212159-63FB5C0D-CCE8-4E70-ADA2-357D6D199E8EQ37315477-9B271492-4557-4C2B-B725-DB58F6143E27Q37326509-D2AEF3D4-0BFF-478C-95D4-190A4F07767CQ37398605-64F0302F-F32B-47F1-BC60-4D52203D5901Q37671065-D54F676C-D80F-4F9E-A2AB-FA32B81ADA6BQ37709932-7D8BC9E7-C3D2-4F9E-B330-0448BCABD064Q37763026-C3499759-23D2-444C-940A-9CCBB6D2E0CCQ37896548-F2EE4DDD-684D-409E-8530-F1B94E605F59Q38107409-459D0872-B10B-43DF-A562-B5BF5FECB12CQ38223118-924C2D89-E8D9-4531-ACC0-BDC9BAEF53B6Q38234457-9206EB7C-CFB7-4958-A23D-FACE8C7D6C68Q38704236-E3DB0786-23BC-4725-91F9-95B03C3343B4Q39496449-8E69EEDB-2484-4A0B-A489-4AEB190C5327Q41474641-6A14D208-FF55-4207-8232-78DD576356D7Q41582254-8A80B8E1-B95F-4264-BBFD-165E8C5E999CQ42644052-82C7BF85-D443-4365-BD55-4FCE543230F8Q43528737-642FD198-F9BE-4D6C-BEED-99A476EC2DAEQ46525878-FB5D13DF-09A7-4F3C-8C39-D45B0274ED55Q47670878-C9230804-E2EA-4F57-843B-36FF5BE43ABC
P2860
Early and widespread cholinergic losses differentiate dementia with Lewy bodies from Alzheimer disease.
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Early and widespread cholinerg ...... bodies from Alzheimer disease.
@ast
Early and widespread cholinerg ...... bodies from Alzheimer disease.
@en
Early and widespread cholinerg ...... bodies from Alzheimer disease.
@nl
type
label
Early and widespread cholinerg ...... bodies from Alzheimer disease.
@ast
Early and widespread cholinerg ...... bodies from Alzheimer disease.
@en
Early and widespread cholinerg ...... bodies from Alzheimer disease.
@nl
prefLabel
Early and widespread cholinerg ...... bodies from Alzheimer disease.
@ast
Early and widespread cholinerg ...... bodies from Alzheimer disease.
@en
Early and widespread cholinerg ...... bodies from Alzheimer disease.
@nl
P2093
P1433
P1476
Early and widespread cholinerg ...... bodies from Alzheimer disease.
@en
P2093
Annette Merdes
Jody Corey-Bloom
Larry A Hansen
Leon J Thal
Michael Alford
Pietro Tiraboschi
P304
P356
10.1001/ARCHPSYC.59.10.946
P407
P577
2002-10-01T00:00:00Z